As per the National Center for Biotechnology Information, in the United States, misdiagnosis rate is approximately 10% to 15%, inflicting 100,000 deaths each year[1]. Bourgeoning occurrences of intricate diseases such as cancer, cardiovascular disease, neurological disease, and pulmonary embolism has been constantly challenging the omnipresent traditional diagnostic techniques. Owing to such inevitable scenario, the demand for advanced diagnostics are stroking the healthcare sector, and the molecular diagnostics market is all set to capitalize on this phenomenon. Molecular diagnostics is a diagnosis technique that utilizes DNA, RNA, and proteins to detect specific and intricate health condition or disease. Owing to its accuracy and effectiveness aiding medical diagnosis outputs, global molecular diagnostic market size hovered around $16.54 billion to $17.44billion as of 2018, and the demand will be progressing at a CAGR of 4.5%-4.8% during the forecast period 2019-2025. Molecular Diag...